These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 28347282

  • 1. Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality.
    Longenecker JC, Waheed S, Bandak G, Murakami CA, McMahon BA, Gelber AC, Atta MG.
    BMC Nephrol; 2017 Mar 27; 18(1):103. PubMed ID: 28347282
    [Abstract] [Full Text] [Related]

  • 2. Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Longenecker JC, Estrella MM, Segev DL, Atta MG.
    Transplantation; 2015 Dec 27; 99(12):2556-64. PubMed ID: 25989501
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC, Chang JM, Yeh SM, Su HM, Chen HC.
    Am J Hypertens; 2013 Feb 27; 26(2):243-9. PubMed ID: 23382409
    [Abstract] [Full Text] [Related]

  • 5. Impact of Uric Acid Levels on Kidney Disease Progression.
    Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB.
    Am J Nephrol; 2017 Feb 27; 46(4):315-322. PubMed ID: 29032376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.
    Clin J Am Soc Nephrol; 2017 Apr 03; 12(4):603-613. PubMed ID: 28348030
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B, Yu DR, Lv JC, Lin Y, Li Q, Yin JZ, Du YY, Tang XL, Mao LC, Li QF, Sun Y, Liu L, Li XF, Fei D, Wei XY, Zhu CF, Cheng XX, Chen HY, Wang YJ.
    Am J Nephrol; 2018 Apr 03; 48(2):127-136. PubMed ID: 30110674
    [Abstract] [Full Text] [Related]

  • 10. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.
    Am J Kidney Dis; 2011 Sep 03; 58(3):398-408. PubMed ID: 21783292
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
    Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M.
    Clin Exp Nephrol; 2018 Apr 03; 22(2):318-327. PubMed ID: 28884361
    [Abstract] [Full Text] [Related]

  • 13. Incidence of chronic kidney disease after orthotopic liver transplantation in a Chinese cohort.
    Peng JC, Li YJ, Wang J-, Zhu ML, Gao Y.
    Clin Exp Nephrol; 2020 Sep 03; 24(9):806-812. PubMed ID: 32504202
    [Abstract] [Full Text] [Related]

  • 14. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S, Maruyama Y, Nishio S, Takahashi Y, Kidoguchi S, Kobayashi C, Takahashi D, Sugano N, Hosoya T, Yokoo T.
    Clin Exp Nephrol; 2015 Dec 03; 19(6):1127-34. PubMed ID: 25967597
    [Abstract] [Full Text] [Related]

  • 15. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.
    Clin Nephrol; 2013 Oct 03; 80(4):256-62. PubMed ID: 23993165
    [Abstract] [Full Text] [Related]

  • 16. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K.
    J Nephrol; 2015 Aug 03; 28(4):451-6. PubMed ID: 25355499
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H, van Diepen M, Qureshi AR, Carrero JJ, Stijnen T, Dekker FW, Evans M.
    Nephrol Dial Transplant; 2015 Dec 03; 30(12):2039-45. PubMed ID: 26185050
    [Abstract] [Full Text] [Related]

  • 20. Serum uric acid levels and long-term outcomes in chronic kidney disease.
    Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K.
    Heart Vessels; 2014 Jul 03; 29(4):504-12. PubMed ID: 23929090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.